MAHAVEER VAKHARIA: Open Payments
NPI 1457366882 · POWDER SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 29 payments from 14 companies in 2025. Trend: 2023 $816 · 2024 $248 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $102 |
| Vanda Pharmaceuticals Inc. | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $16 |
Products named: CAPLYTA, FANAPT, AUSTEDO XR, REXULTI, Auvelity, TRINTELLIX, Subvenite, ARISTADA.
Industry payments across GA — which companies pay providers there.
